The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Insmed Incorporated

Insmed Incorporated
Nasdaq: INSM
Change
symbol:
     
 PROFILE
Insmed isn't insensitive about insulin. The company is developing drugs to treat metabolic and endocrine diseases caused by a patient's resistance to insulin. Its lead drug candidate, INS-1, has shown an ability to fight type 2 diabetes and polycystic ovary syndrome, a leading cause of infertility among US women, by restoring tissue's sensitivity to insulin. Insmed has licensed the drug to Japan's Taisho Pharmaceuticals for development and marketing in Asia. The company's pipeline also includes SomatoKine, which has possible applications for type 1 and type 2 diabetes. Through a joint venture with Elan, subsidiary Celtrix Pharmaceutical is developing SomatoKine as a possible treatment for osteoporosis.

 COMPETITION
Bristol-Myers Squibb Company (BMY)
GlaxoSmithKline plc (GSK)
Pfizer Inc (PFE)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 0.10
1-Yr. Sales Growth: (91.4)%
Employees: 40
Revenue per employee: $2,500.00

 KEY PEOPLE
• Geoffrey Allan
    CEO
• Michael D. Baer
    CFO

 CONTACT INFO
800 E. Leigh St.
Richmond, VA 23219
US
Phone: 804-828-6893
Fax: 804-828-6894
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001